Up to Date Management of DCIS and Future Directions
Rodrigo Arrangoiz, Fernando Cordera, Eduardo Moreno, Enrique Luque-de-Leon, Manuel Muñoz

Adv. Breast Cancer Res. Vol.9 No.3, June 18, 2020
DOI: 10.4236/abcr.2020.93007

Risk Factors for Breast Cancer in the City of Douala: A Case Control Study
Engbang Ndamba Jean Paul, Essome Henri, Mve Koh Valère, Sukam Noutadjeu Diane Sara, Mboudou Telesphore Emile

Adv. Breast Cancer Res. Vol.9 No.3, May 27, 2020
DOI: 10.4236/abcr.2020.93006

Cardiac Safety with High Cumulative Dose of Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer Previously Treated with Conventional Anthracyclines
Ahmed Refaat, Dalia O. Mohamed, Elsayed Mostafa Ali, Salah Mabrouk Khallaf

Adv. Breast Cancer Res. Vol.9 No.3, May 18, 2020
DOI: 10.4236/abcr.2020.93005

Information Needs of Breast Cancer Patients at Cancer Diseases Hospital, Lusaka, Zambia
Beauty Lilala Namushi, Marjorie Kabinga Makukula, Patricia Katowa Mukwato

Adv. Breast Cancer Res. Vol.9 No.2, April 26, 2020
DOI: 10.4236/abcr.2020.92004

Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer
Salah Mabrouk Khallaf, Jasmine Roshdy, Abeer Ibrahim

Adv. Breast Cancer Res. Vol.9 No.2, April 10, 2020
DOI: 10.4236/abcr.2020.92003